Plasma free N-terminal fibronectin 30-kDa domain as a marker of endothelial dysfunction in type 1 diabetes mellitus
- 1 April 1990
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 20 (2Part1) , 171-176
- https://doi.org/10.1111/j.1365-2362.1990.tb02265.x
Abstract
The plasma free N-terminal fibronectin 30-kDa domain was measured in 44 type 1 diabetic patients and in 20 healthy subjects. A significantly raised mean concentration of a free N-terminal fibronectin 30-kDa domain was found in plasma of diabetic patients with proliferative retinopathy as compared with healthy persons (P < 0.001). A positive correlation was observed between free N-terminal fibronectin 30-kDa domain and von Willebrand factor in plasma of all examined subjects (r = 0.62, P < 0.01). A similar correlation was present between 30-kDa domain and albuminuria (r = 0.56, P < 0.01). However, no relationship was found between fibronectin and 30-kDa domain and control of diabetes as assessed by fructosamine concentration. The free N-terminal fibronectin 30-kDa domain may be used as a marker of actual endothelial cell dysfunction in diabetes.Keywords
This publication has 29 references indexed in Scilit:
- Increased Plasma Fibronectin Concentration in Diabetic Patients With MicroalbuminuriaDiabetes Care, 1988
- Diminished Adhesion of Endothelial Aortic Cells on Fibronectin and Collagen Layers after Nonenzymatic GlycationExperimental and Clinical Endocrinology & Diabetes, 1988
- The effect of glycemic control on plasma soluble fibrin monomer complexes and fibronectin in diabetic patients.The Tohoku Journal of Experimental Medicine, 1987
- Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth: structure-function correlationsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Factors of the Hemostatic System in Diabetic PatientsPathophysiology of Haemostasis and Thrombosis, 1986
- Plasma Factor XIII and some other Haemostasis Parameters in Patients with Diabetic AngiopathyActa Haematologica, 1986
- Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitusDiabetes, 1985
- Variant endothelial cells. Fibronectin as a transducer of signals for migration and neovascularisationJournal of Cellular Physiology, 1980
- Synthesis of fibronectin by cultured human endothelial cells.The Journal of Experimental Medicine, 1978
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965